您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > WYC-210
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
WYC-210
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
WYC-210图片
CAS NO:2131803-93-3
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议

产品介绍
WYC-210,Tazarotene的衍生物,是一种视黄醇类化合物,具有较低的抗癌活性。
Cas No.2131803-93-3
别名2-((4,4-二甲基-1-氧化硫代苯并二氢吡喃-6-基)乙炔基)嘧啶-5-羧酸
Canonical SMILESO=C(C1=CN=C(C#CC2=CC=C3C(C(C)(C)CCS3=O)=C2)N=C1)O
分子式C18H16N2O3S
分子量340.4
储存条件Store at -20℃
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

WYC-210, a Tazarotene derivative, is a retinoid compound with lower anticancer activity[1].

WYC-210 (10 μM; 5 days) inhibits cell growth of B16-F1 TRC cells with an inhibition rate of 18.1%[1].

[1]. Cao, Xin, et al. Preparation of the retinoid compound and their application as anticancer agents. WO2017152725A1.